PT1771433E - Processo para o isolamento de alfa-mangostina - Google Patents

Processo para o isolamento de alfa-mangostina Download PDF

Info

Publication number
PT1771433E
PT1771433E PT05762093T PT05762093T PT1771433E PT 1771433 E PT1771433 E PT 1771433E PT 05762093 T PT05762093 T PT 05762093T PT 05762093 T PT05762093 T PT 05762093T PT 1771433 E PT1771433 E PT 1771433E
Authority
PT
Portugal
Prior art keywords
mangostin
alpha
isolation
mangosteen
rind
Prior art date
Application number
PT05762093T
Other languages
English (en)
Inventor
Hans-Peter Ignatow
Rainer Sobotta
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT1771433E publication Critical patent/PT1771433E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT05762093T 2004-07-17 2005-07-12 Processo para o isolamento de alfa-mangostina PT1771433E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004034683A DE102004034683A1 (de) 2004-07-17 2004-07-17 Verfahren zur Isolierung von α-Mangostin

Publications (1)

Publication Number Publication Date
PT1771433E true PT1771433E (pt) 2008-05-05

Family

ID=34972831

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05762093T PT1771433E (pt) 2004-07-17 2005-07-12 Processo para o isolamento de alfa-mangostina

Country Status (10)

Country Link
US (1) US7285672B2 (pt)
EP (1) EP1771433B1 (pt)
AT (1) ATE388948T1 (pt)
DE (2) DE102004034683A1 (pt)
DK (1) DK1771433T3 (pt)
ES (1) ES2302211T3 (pt)
PL (1) PL1771433T3 (pt)
PT (1) PT1771433E (pt)
SI (1) SI1771433T1 (pt)
WO (1) WO2006008030A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2587628A1 (en) * 2004-11-16 2006-05-26 Renaissance Herbs, Inc. Pharmaceutical and therapeutic compositions derived from garcinia mangostana l plant
WO2009093255A2 (en) 2008-01-21 2009-07-30 Ganga Raju Gokaraju A new nutraceutical composition from garcinia mangostana
CN101525328B (zh) * 2008-03-06 2012-08-22 陕西嘉禾植物化工有限责任公司 从山竹果皮中提取α-倒捻子素的方法
CN102151258B (zh) * 2011-02-18 2012-10-10 夏铮 α-倒捻子素在制备阿尔兹海默氏病药物中的应用
US20160148226A1 (en) * 2014-11-21 2016-05-26 Oracle International Corporation System and method for forecasting and managing returned merchanidse in retail
CN105130945A (zh) * 2015-08-30 2015-12-09 常州市鼎日环保科技有限公司 从山竹中分离纯化α-倒捻子素的方法
CN111620847B (zh) * 2020-05-09 2022-02-22 完美（广东）日用品有限公司 一种α-倒捻子素的纯化方法及含α-倒捻子素的防晒剂
TWI789606B (zh) 2020-07-21 2023-01-11 潤鴻生物科技股份有限公司 山竹果殼萃取物及其製備方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4638977B2 (ja) * 2000-08-02 2011-02-23 株式会社ロッテ シクロオキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
EP1771433A1 (de) 2007-04-11
US20060014967A1 (en) 2006-01-19
ES2302211T3 (es) 2008-07-01
EP1771433B1 (de) 2008-03-12
DE102004034683A1 (de) 2006-02-02
DE502005003227D1 (de) 2008-04-24
US7285672B2 (en) 2007-10-23
SI1771433T1 (sl) 2008-08-31
PL1771433T3 (pl) 2008-08-29
WO2006008030A1 (de) 2006-01-26
ATE388948T1 (de) 2008-03-15
DK1771433T3 (da) 2008-04-21

Similar Documents

Publication Publication Date Title
PL1771433T3 (pl) Sposób izolowania alfa - mangostyny
TW200716646A (en) (S)-N-methylnaltrexone
TW200801262A (en) Method for purifying silicon
EP2194043A3 (en) Processes and intermediates
IL185731A0 (en) Purification of montelukast
TW200508201A (en) Novel process for the preparation of roflumilast
WO2006015035A8 (en) Useful compounds for hpv infection
WO2006136357A3 (de) Kristalline modifikationen des pyraclostrobins
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
SG138520A1 (en) Tripentyl citrates and their use
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
DK1404821T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer under avnendelse af stammer fra familien Enterobacteriaceae
IL185031A0 (en) Method for the preparation of pregabalin and salts thereof
RS20050235A (en) Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
MXPA05013202A (es) Tableta de multiples capas oralmente dispersable.
WO2006015178A3 (en) Growth factor encapsulation system for enhancing bone formation
WO2006130786A3 (en) Water treatment system and process
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
IL165988A0 (en) Process for the preparation of fibrinogen
WO2006089286A3 (en) Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor compounds useful for the treatment and prevention of pain and screening methods therefor
WO2007120263A3 (en) Preparation of dutasteride
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
TW200732345A (en) Niobium compound
WO2007013123A8 (en) Cyclodextrins for blood detoxification
WO2006111720A3 (en) Use